In-Treatment Kinetics of Peripheral Blood Immune Markers in PD-L1 High Non-Small Cell Lung Cancer and Prognostic Relevance for Immunotherapy Outcomes.

Cancers (Basel) · 2026 · PMC13204403 · PMID 42192983

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a negative trendno p-value reported

Assessment of cell counts and biochemical markers revealed a statistically significant negative association of baseline CRP (OR = 0.81, 95%CI: 0.63–0.98, p < 0.05) with CB6, as well as a negative trend for CAR (OR = 0.55, 95%CI: 0.24–1.02, p 0.06).

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.